We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Successful management of an arteriovenous malformation with trametinib in a patient with capillary‐malformation arteriovenous malformation syndrome and cardiac compromise.
- Authors
Nicholson, Cynthia L.; Flanagan, Siobhan; Murati, Michael; Boull, Christina; McGough, Erin; Ameduri, Rebecca; Weigel, Brenda; Maguiness, Sheilagh
- Abstract
Capillary malformation‐arteriovenous malformation (CM‐AVM) syndrome is an autosomal dominant condition characterized by multifocal, noncontiguous pink patches on the skin that often have a surrounding pale halo. In some cases, an association with a fast flow, arteriovenous malformation (AVM) can be identified. Here, we describe a case report of a 16‐year‐old woman with CM‐AVM syndrome and significant cardiac compromise successfully treated with trametinib, a mitogen‐activated protein kinase (MEK) inhibitor.
- Subjects
MITOGEN-activated protein kinases; ARTERIOVENOUS malformation; SYNDROMES
- Publication
Pediatric Dermatology, 2022, Vol 39, Issue 2, p316
- ISSN
0736-8046
- Publication type
Article
- DOI
10.1111/pde.14912